Anna Dahlgren

Title: Anna Dahlgren: Innovator in Pharmaceutical Formulations

Introduction

Anna Dahlgren is a notable inventor based in Sweden, recognized for her contributions to the field of pharmaceutical formulations. With a focus on creating abuse-resistant drug delivery systems, she has made significant strides in improving patient safety and treatment efficacy.

Latest Patents

Anna Dahlgren holds two notable patents. The first is titled "Abuse Resistant Formulation," which describes a sustained-release pharmaceutical composition. This composition features a solid, continuous network with high mechanical strength, containing pores that intersperse a mixture of an active ingredient and a film-forming agent. This innovative formulation is particularly useful for creating abuse-resistant opioid analgesics for chronic pain management. The second patent is for a "Transdermal Drug Administration Device." This device includes a drug delivery element designed to be placed against a patient's skin, featuring a sustained-release pharmaceutical composition. The active pharmaceutical ingredient is co-formedly interspersed within the solid network of the carrier material, enhancing the effectiveness of drug delivery.

Career Highlights

Anna Dahlgren is currently associated with Emplicure AB, where she continues to develop innovative pharmaceutical solutions. Her work focuses on enhancing the safety and effectiveness of drug formulations, particularly in the context of pain management.

Collaborations

Some of her notable coworkers include Hakan Engqvist and Susanne Bredenberg, who contribute to the collaborative efforts at Emplicure AB.

Conclusion

Anna Dahlgren's work in pharmaceutical innovations highlights her commitment to improving patient care through advanced drug formulations. Her patents reflect a significant contribution to the field, particularly in creating safer medication options.